21 Oct 2024 17:00 CEST

Issuer

Vistin Pharma ASA

Please find attached the first half 2024 financial report including the
Responsibility Statement.

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97 05 36 21
Alexander.karlsen@vistin.com

This information is subject to the disclosure requirements pursuant to Section
5-12 the Norwegian Securities Trading Act


630018_Vistin Pharma ASA Q2 report 2024.pdf

Source

Vistin Pharma ASA

Provider

Oslo Børs Newspoint

Company Name

VISTIN PHARMA

ISIN

NO0010734122

Symbol

VISTN

Market

Oslo Børs